News
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
11h
Verywell Health on MSNMedication Options for Managing Kidney DiseaseExplore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...
According to Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, some of the most concerning side effects of GLP-1 ...
Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.
Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...
Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...
GOODRICKE GROUP LIMITED has, on 16th April, 2025, executed a Non-binding MoU with SOMBARIA AGRI PRODUCTS PRIVATE LIMITED for ...
The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results